Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADVAX: Radiotherapy + Ipilimumab in Metastatic Melanoma
NCT01497808Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Nov 2011
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab in melanoma, sponsored by Abramson Cancer Center. Started Nov 2011; status: completed.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01497808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497808.